These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17886559)
1. Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status. Clark AJ; Dos Santos WG; McCready J; Chen MY; Van Meter TE; Ware JL; Wolber SB; Fillmore H; Broaddus WC J Neurosurg; 2007 Sep; 107(3):586-92. PubMed ID: 17886559 [TBL] [Abstract][Full Text] [Related]
2. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness. Chidambaram A; Fillmore HL; Van Meter TE; Dumur CI; Broaddus WC J Neurosurg; 2012 Apr; 116(4):843-53. PubMed ID: 22313360 [TBL] [Abstract][Full Text] [Related]
3. Analysis of p53 gene mutations in human glioma cell lines. Koga H; Zhang S; Washiyama K; Ichikawa T; Onda K; Kumanishi T Noshuyo Byori; 1996 Apr; 13(1):1-10. PubMed ID: 8916120 [TBL] [Abstract][Full Text] [Related]
4. Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. Dennis SL; Manji SS; Carrington DP; Scarcella DL; Ashley DM; Smith PJ; Algar EM Int J Cancer; 2002 Feb; 97(5):713-5. PubMed ID: 11807803 [TBL] [Abstract][Full Text] [Related]
5. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714 [TBL] [Abstract][Full Text] [Related]
7. Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary. Makrigiannakis A; Amin K; Coukos G; Tilly JL; Coutifaris C J Clin Endocrinol Metab; 2000 Jan; 85(1):449-59. PubMed ID: 10634423 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of p53 dependent apoptosis in glia-derived tumors of the brain]. Kaczmarczyk R; Słodziński H; Trojanowski T; Polz-Dacewicz M Neurol Neurochir Pol; 2001; 35 Suppl 5():30-3. PubMed ID: 11935677 [TBL] [Abstract][Full Text] [Related]
9. RIZ1: a potential tumor suppressor in glioma. Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953 [TBL] [Abstract][Full Text] [Related]
10. Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Hashiba T; Izumoto S; Kagawa N; Suzuki T; Hashimoto N; Maruno M; Yoshimine T Neurol Med Chir (Tokyo); 2007 Apr; 47(4):165-70; discussion 170. PubMed ID: 17457020 [TBL] [Abstract][Full Text] [Related]
11. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas. Iwadate Y; Fujimoto S; Tagawa M; Namba H; Sueyoshi K; Hirose M; Sakiyama S Int J Cancer; 1996 Jun; 69(3):236-40. PubMed ID: 8682593 [TBL] [Abstract][Full Text] [Related]
12. Expression of p53 and prognosis in children with malignant gliomas. Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R; N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530 [TBL] [Abstract][Full Text] [Related]
13. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
15. Absence of p53 autoantibodies in sera from glioma patients. Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045 [TBL] [Abstract][Full Text] [Related]
16. [Mutations of p53 gene in 41 cases of human brain gliomas]. Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456 [TBL] [Abstract][Full Text] [Related]
17. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y; San-Marina S; Yang L; Khoury H; Minden MD Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147 [TBL] [Abstract][Full Text] [Related]
18. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944 [TBL] [Abstract][Full Text] [Related]
19. WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells. Koesters R; Linnebacher M; Coy JF; Germann A; Schwitalle Y; Findeisen P; von Knebel Doeberitz M Int J Cancer; 2004 Apr; 109(3):385-92. PubMed ID: 14961577 [TBL] [Abstract][Full Text] [Related]
20. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants. Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]